Top compounds associated with response to CELF5


Feature Type Standardized
Nominal ANOVA
mRNA TL-2-105 GDSC1000 pan-cancer AAC 0.15 5e-06
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.17 7e-06
mRNA BIBR-1532 CTRPv2 pan-cancer AAC 0.17 1e-05
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA bendamustine CTRPv2 pan-cancer AAC 0.17 2e-05
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA Oxaliplatin CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA CX-5461 GDSC1000 pan-cancer AAC 0.14 3e-05
Download CSV